Ginkgo Bioworks Holdings Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 604
Employees
  • Stock Symbol
  • DNA
Stock Symbol
  • Investments
  • 17
  • Share Price
  • $2.97
  • (As of Thursday Closing)

Ginkgo Bioworks Holdings General Information

Description

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Stock Exchange
NYS
Primary Office
  • 27 Drydock Avenue
  • 8th Floor
  • Boston, MA 02210
  • United States
+1 (877) 000-0000

Ginkgo Bioworks Holdings Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ginkgo Bioworks Holdings Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.97 $2.99 $2.62 - $15.86 $4.45B 1.67B 12.3M -$0.09

Ginkgo Bioworks Holdings Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
Revenue 76,657 76,657 54,184 40,000
EBITDA (111,167) (111,167) (112,415)
Net Income (126,609) (126,609) (119,327)
Total Assets 675,153 675,153 697,318
Total Debt 17,003 17,003 17,365
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ginkgo Bioworks Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ginkgo Bioworks Holdings‘s full profile, request access.

Request a free trial

Ginkgo Bioworks Holdings Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Ginkgo Bioworks Holdings‘s full profile, request access.

Request a free trial

Ginkgo Bioworks Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers.
Biotechnology
Boston, MA
604 As of 2021
00.000
000000000 00.000

0000000

niam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute i
0000000000000
Medford, MA
0 As of 0000
00.000
00.00 0000-00-00
000000&0 00.000

000 0000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cul
0000000000000
Le Kremlin-Bicêtre, France
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ginkgo Bioworks Holdings Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
enEvolv Formerly VC-backed Medford, MA 0 00.000 000000&0 00.000
000 000000 Venture Capital-Backed Le Kremlin-Bicêtre, France 000 00000 00000000000 00000
00000000 0000 Formerly VC-backed Warren, NJ 00 00000 000000&0 00000
00000000000 000000 Venture Capital-Backed Vancouver, Canada 00 000.00 0000000000 000.00
0000 00000000 Venture Capital-Backed Toronto, Canada 000 00000 00000000000 00000
You’re viewing 5 of 19 competitors. Get the full list »

Ginkgo Bioworks Holdings Patents

Ginkgo Bioworks Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210032604-A1 Methods and compositions involving promoters derived from yarrowia lipolytica Pending 29-Jul-2019 0000000000
CA-3137348-A1 Methanol utilization Pending 19-Apr-2019 0000000000
US-20210071209-A1 Biosynthesis of cannabinoids and cannabinoid precursors Pending 25-Feb-2019 00000000
CA-3130763-A1 Biosynthesis of cannabinoids and cannabinoid precursors Pending 25-Feb-2019 00000000
EP-3877519-A1 Biosynthesis of mogrosides Pending 09-Nov-2018 C12Y504/99033
To view Ginkgo Bioworks Holdings’s complete patent history, request access »

Ginkgo Bioworks Holdings Executive Team (16)

Name Title Board Seat Contact Info
Jason Kelly Ph.D Chief Executive Officer & Board Member
Reshma Shetty Ph.D Chief Operating Officer, Operations & Board Member
Barry Canton Ph.D Co-Founder & Chief Technology Officer
Zach Smith Director, Business Development
Adam Harmon Director of Diversity & Inclusion
You’re viewing 5 of 16 executive team members. Get the full list »

Ginkgo Bioworks Holdings Board Members (9)

Name Representing Role Since
Arie Belldegrun MD Self Board Member 000 0000
Christian Henry Illumina Board Member 000 0000
Harry Sloan JD Self Board Member 000 0000
Jason Kelly Ph.D Ginkgo Bioworks Holdings Chief Executive Officer & Board Member 000 0000
Marijn Dekkers Ph.D Novalis LifeSciences Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Ginkgo Bioworks Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ginkgo Bioworks Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ginkgo Bioworks Holdings‘s full profile, request access.

Request a free trial

Ginkgo Bioworks Holdings Investments & Acquisitions (17)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 14-Mar-2022 0000000000 Biotechnology 00000 000
0000000 00000 19-Jan-2022 0000000000 Other Healthcare Services 0000000 0
0000000 00000 17-Sep-2021 0000000000 Special Purpose Acquisition Company (SPAC) 00000 000
0000000 00000 02-Sep-2021 00000 0000 0000 Other Materials 00000 000
Kalo Ingredients 01-Jun-2021 Later Stage VC 0000 Biotechnology
You’re viewing 5 of 17 investments and acquisitions. Get the full list »

Ginkgo Bioworks Holdings Subsidiaries (2)

Company Name Industry Location Founded
Project Beacon COVID-19 Other Healthcare Services Cambridge, MA 2020
00000000 Biotechnology Woburn, MA 0000
To view Ginkgo Bioworks Holdings’s complete subsidiaries history, request access »

Ginkgo Bioworks Holdings Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 11-Jun-2019 0000 0000 Completed
  • 000000 00000000 00
To view Ginkgo Bioworks Holdings’s complete exits history, request access »